The co-treatment of rosuvastatin with dapagliflozin synergistically inhibited apoptosis via activating the PI3K/AKt/mTOR signaling pathway in myocardial ischemia/reperfusion injury rats

Humoral transfer and intramyocardial signal transduction of protection by remote ischemic perconditioning in pigs, rats, and mice

(2018) Andreas Skyschally et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Recombinant human brain natriuretic peptide regulates PI3K/AKT/mTOR pathway through lncRNA EGOT to attenuate hypoxia-induced injury in H9c2 cardiomyocytes

(2018) Chengxi Zhang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Compound K Inhibits Autophagy-Mediated Apoptosis Through Activation of the PI3K-Akt Signaling Pathway Thus Protecting Against Ischemia/Reperfusion Injury

(2018) Xiangyan Li et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Pravastatin improves risk factors but not ischaemic tolerance in obese rats

(2018) Massa Oi et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Cardioprotection of dapagliflozin and vildagliptin in rats with cardiac ischemia-reperfusion injury

(2017) Pongpan Tanajak et al.   JOURNAL OF ENDOCRINOLOGY

Dapagliflozin and saxagliptin tablets for adults with type 2 diabetes

(2017) André J. Scheen   Expert Review of Clinical Pharmacology

Tanshinone IIA protects against myocardial ischemia reperfusion injury by activating the PI3K/Akt/mTOR signaling pathway

(2016) Qiang Li et al.   BIOMEDICINE & PHARMACOTHERAPY

IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assays

(2015) Fred S. Apple et al.   CLINICAL BIOCHEMISTRY

ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data

(2015) Jing Li et al.   LANCET

Targeting Myocardial Reperfusion Injury — The Search Continues

(2015) Derek J. Hausenloy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Reduced Oxidative Stress in STEMI Patients Treated by Primary Percutaneous Coronary Intervention and with Antioxidant Therapy: A Systematic Review

(2014) Sarah Ekeløf et al.   CARDIOVASCULAR DRUGS AND THERAPY

Effects of rosuvastatin on ADMA, rhokinase, NADPH oxidase, caveolin-1, hsp 90 and NFkB levels in a rat model of myocardial ischaemia-reperfusion : cardiovascular topic

(2014) Oktay Burma et al.   Cardiovascular Journal of Africa

Inhibition of Autophagy via Activation of PI3K/Akt Pathway Contributes to the Protection of Ginsenoside Rb1 against Neuronal Death Caused by Ischemic Insults

(2014) Tianfei Luo et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Selective inhibition of class I but not class IIb histone deacetylases exerts cardiac protection from ischemia reperfusion

(2014) Sverre E. Aune et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Quercetin postconditioning attenuates myocardial ischemia/reperfusion injury in rats through the PI3K/Akt pathway

(2013) Y. Wang et al.   BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH

Regulatory T cells contribute to rosuvastatin-induced cardioprotection against ischemia-reperfusion injury

(2013) Dan Ke et al.   CORONARY ARTERY DISEASE

How to use high-sensitivity cardiac troponins in acute cardiac care

(2012) K. Thygesen et al.   EUROPEAN HEART JOURNAL

Targeting disease through novel pathways of apoptosis and autophagy

(2012) Kenneth Maiese et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Rosuvastatin Changes Cytokine Expressions in Ischemic Territory and Preserves Heart Function After Acute Myocardial Infarction in Rats

(2012) Xinying Hu et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

The cardioprotective efficacy of TVP1022 in a rat model of ischaemia/reperfusion

(2011) Offir Ertracht et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cell Death in the Pathogenesis of Heart Disease: Mechanisms and Significance

(2010) Russell S. Whelan et al.   Annual Review of Physiology